RNLXD (Renalytix) FFO


RNLXD Renalytix PLC RNLXD
46 GF Score
Price $4.11
GF Value $10.82
! 3 Warning Signs
View Full Analysis

What is Renalytix FFO?

FFO (Funds from operations) only applies to REITs.

RNLXD
46GF Score
Renalytix PLC RNLXD
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Renalytix (RNLXD) Overvalued in 2026?

Based on GuruFocus' analysis, Renalytix stock appears to be undervalued. The current stock price of $4.11 is trading 62% below its estimated GF Value™ of $10.82.

Key valuation signals for RNLXD:

  • FFO:
  • GF Value™: $10.82 vs. price of $4.11 (62% below fair value)
  • GF Score™: 46/100 with 3 warning signs

No single metric tells the full story. See the RNLXD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Renalytix Business Description

Other Exchanges RENXF:USARENX:UK2O9:Germany
Address 2 Leman Street, London, GBR, E1W 9US
Renalytix PLC is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease. Its product, KidneyIntelX, is designed to improve kidney disease diagnosis and prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery. The company's service, KidneyIntelX.dkd, enables the assessment of risk for early-stage chronic kidney disease progression. KidneyIntelX uses a proprietary algorithm combining blood-based biomarkers, inherited genetics, and electronic health record data to generate a patient risk score predicting rapid kidney function decline.
46GF Score

Get the complete analysis for RNLXD

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.11
Price
$10.82
GF Value